166 related articles for article (PubMed ID: 35107070)
1. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
[TBL] [Abstract][Full Text] [Related]
4. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
5. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
Wedgeworth E; Glover M; Irvine AD; Neri I; Baselga E; Clayton TH; Beattie PE; Bjerre JV; Burrows NP; Foelster-Holst R; Hedelund L; Hernandez-Martin A; Audrain H; Bhate K; Brown SJ; Baryschpolec S; Darne S; Durack A; Dvorakova V; Gach J; Goldstraw N; Goodyear H; Grabczynska S; Greenblatt D; Halpern J; Hearn RM; Hoey S; Hughes B; Jayaraj R; Johansson EK; Lam M; Leech S; O'Regan GM; Morrison D; Porter W; Ramesh R; Schill T; Shaw L; Taylor AE; Taylor R; Thomson J; Tiffin P; Tsakok M; Janmohamed SR; Laguda B; McPherson T; Oranje AP; Patrizi A; Ravenscroft JC; Shahidullah H; Solman L; Svensson A; Wahlgren CF; Hoeger PH; Flohr C
Br J Dermatol; 2016 Mar; 174(3):594-601. PubMed ID: 26473312
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
Lie E; Püttgen KB
Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
[TBL] [Abstract][Full Text] [Related]
7. Propranolol-resistant infantile haemangiomas.
Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
[TBL] [Abstract][Full Text] [Related]
8. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
9. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
[TBL] [Abstract][Full Text] [Related]
10. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
11. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
12. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
[TBL] [Abstract][Full Text] [Related]
13. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.
Baselga E; Roe E; Coulie J; Muñoz FZ; Boon LM; McCuaig C; Hernandez-Martín A; Gich I; Puig L
JAMA Dermatol; 2016 Nov; 152(11):1239-1243. PubMed ID: 27540637
[TBL] [Abstract][Full Text] [Related]
16. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
17. Topical propranolol for infantile haemangiomas: a systematic review.
Price A; Rai S; Mcleod RWJ; Birchall JC; Elhassan HA
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2083-2089. PubMed ID: 29569772
[TBL] [Abstract][Full Text] [Related]
18. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
19. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
